Amgen Current Deferred Revenue (Quarterly) Analysis

Amgen, Inc. (AMGN)

329.63 -3.30 (-0.99%) USD | NASDAQ | Dec 29, 16:00

329.86 +0.23 (+0.07%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for AMGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	--
Gilead Sciences, Inc.	--
Johnson & Johnson	--
Eli Lilly & Co.	--
Regeneron Pharmaceuticals, Inc.	Upgrade